tiprankstipranks
Guangzhou Baiyunshan Pharmaceutical Holdings Company Class H (GZPHF)
:GZPHF
Holding GZPHF?
Track your performance easily

Guangzhou Baiyunshan Pharmaceutical Holdings Company (GZPHF) Stock Price & Analysis

3 Followers

GZPHF Stock Chart & Stats


Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

3.73%93.64%
Insiders
― Other Institutional Investors
93.64% Public Companies and
Individual Investors

GZPHF FAQ

What was Guangzhou Baiyunshan Pharmaceutical Holdings Company Class H’s price range in the past 12 months?
Guangzhou Baiyunshan Pharmaceutical Holdings Company Class H lowest stock price was $1.72 and its highest was $3.23 in the past 12 months.
    What is Guangzhou Baiyunshan Pharmaceutical Holdings Company Class H’s market cap?
    Guangzhou Baiyunshan Pharmaceutical Holdings Company Class H’s market cap is $5.69B.
      When is Guangzhou Baiyunshan Pharmaceutical Holdings Company Class H’s upcoming earnings report date?
      Guangzhou Baiyunshan Pharmaceutical Holdings Company Class H’s upcoming earnings report date is Mar 17, 2025 which is in 50 days.
        How were Guangzhou Baiyunshan Pharmaceutical Holdings Company Class H’s earnings last quarter?
        Currently, no data Available
        Is Guangzhou Baiyunshan Pharmaceutical Holdings Company Class H overvalued?
        According to Wall Street analysts Guangzhou Baiyunshan Pharmaceutical Holdings Company Class H’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Guangzhou Baiyunshan Pharmaceutical Holdings Company Class H pay dividends?
          Guangzhou Baiyunshan Pharmaceutical Holdings Company Class H does not currently pay dividends.
          What is Guangzhou Baiyunshan Pharmaceutical Holdings Company Class H’s EPS estimate?
          Guangzhou Baiyunshan Pharmaceutical Holdings Company Class H’s EPS estimate is 0.04.
            How many shares outstanding does Guangzhou Baiyunshan Pharmaceutical Holdings Company Class H have?
            Guangzhou Baiyunshan Pharmaceutical Holdings Company Class H has 219,900,000 shares outstanding.
              What happened to Guangzhou Baiyunshan Pharmaceutical Holdings Company Class H’s price movement after its last earnings report?
              Currently, no data Available
              Which hedge fund is a major shareholder of Guangzhou Baiyunshan Pharmaceutical Holdings Company Class H?
              Currently, no hedge funds are holding shares in GZPHF
              ---

              Guangzhou Baiyunshan Pharmaceutical Holdings Company Stock Smart Score

              10
              Unlock Smart Score
              1
              2
              3
              4
              5
              6
              7
              8
              9
              10

              Company Description

              Guangzhou Baiyunshan Pharmaceutical Holdings Company Class H

              Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd is active in the Chinese healthcare sector. The company manufactures pharmaceutical products including antibiotics, vasodilators, and traditional Chinese medical therapies in preparations such as injection, tablet, capsule, powder, cream, and oral liquid. Its operations are divided into three main segments: pharmaceutical manufacturing, pharmaceutical distribution & retail, and health products. The greater portion of its revenue comes from its pharmaceutical activities in patent medicine, raw materials, distribution, and retail. The rest of its revenues come from its beverage, food, cosmetics, and health products. The company's primary market is China.
              ---
              Similar Stocks
              Company
              Price & Change
              Follow
              Sino Biopharmaceutical
              CSPC Pharmaceutical Group
              Livzon Pharmaceutical Group
              Shenzhou International Group Holdings
              China Resources Pharmaceutical Group Ltd.
              Popular Stocks
              ---
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis